Literature DB >> 10765049

Alzheimer disease and vascular dementia: relationships with fasting glucose and insulin levels.

M Carantoni1, G Zuliani, M R Munari, K D'Elia, E Palmieri, R Fellin.   

Abstract

Cerebrovascular disease and Alzheimer disease are the leading causes of dementia in elderly subjects. In spite of it, relatively little is known about the pathogenesis and risk factors for dementia. We evaluated fasting plasma glucose and insulin, albumin, lipids, Lp(a) and uric acid levels in nondiabetic patients of both sexes affected by vascular dementia (VD) and senile dementia of the Alzheimer type (SDAT) as well as in a control group of age-matched nondemented subjects. Following a covariance analysis by gender, body mass index, albumin levels and prevalence of arterial hypertension, total and LDL cholesterol as well as HDL cholesterol levels were not significantly different among the three groups. Fasting glucose (p < 0.001 and p < 0.005, respectively) and insulin levels (p < 0.05 for both differences) were higher in patients with VD and SDAT than in control subjects. Our data show that nondiabetic patients with VD or SDAT have higher fasting glucose and insulin levels than healthy control subjects. These metabolic characteristics were not influenced by differences in gender, adiposity, nutritional status, lipids or presence of arterial hypertension. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10765049     DOI: 10.1159/000017232

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  15 in total

1.  Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models.

Authors:  Elena L Paley; Galina Denisova; Olga Sokolova; Natalia Posternak; Xukui Wang; Anna-Liisa Brownell
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

2.  Shared genetic architecture between metabolic traits and Alzheimer's disease: a large-scale genome-wide cross-trait analysis.

Authors:  Zhaozhong Zhu; Yifei Lin; Xihao Li; Jane A Driver; Liming Liang
Journal:  Hum Genet       Date:  2019-02-25       Impact factor: 4.132

3.  Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin.

Authors:  Jill K Morris; Eric D Vidoni; Jonathan D Mahnken; Robert N Montgomery; David K Johnson; John P Thyfault; Jeffrey M Burns
Journal:  Neurobiol Aging       Date:  2015-12-01       Impact factor: 4.673

4.  Measures of adiposity and dementia risk in elderly persons.

Authors:  José A Luchsinger; Bindu Patel; Ming-Xin Tang; Nicole Schupf; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-03

Review 5.  Inverse Association Between Serum Uric Acid Levels and Alzheimer's Disease Risk.

Authors:  Na Du; Donghua Xu; Xu Hou; Xuejia Song; Cancan Liu; Ying Chen; Yangang Wang; Xin Li
Journal:  Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.590

6.  Potential hippocampal region atrophy in diabetes mellitus type 2: a voxel-based morphometry VSRAD study.

Authors:  Kazutoshi Kamiyama; Akihiko Wada; Masaki Sugihara; Souichi Kurioka; Kumi Hayashi; Takafumi Hayashi; Takeshi Yoshisako; Nobuko Yamamoto; Youji Tsuchie; Syuhei Yamaguchi; Toshitsugu Sugimoto; Hajime Kitagaki
Journal:  Jpn J Radiol       Date:  2010-05-29       Impact factor: 2.374

7.  Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.

Authors:  Giovanni Zuliani; Michela Perrone Donnorso; Cristina Bosi; Angelina Passaro; Edoardo Dalla Nora; Amedeo Zurlo; Francesco Bonetti; Alessia F Mozzi; Claudio Cortese
Journal:  BMC Neurol       Date:  2011-10-04       Impact factor: 2.474

8.  Dicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and beta-amyloid peptide-(25-35)-induced amnesia.

Authors:  Zinaida I Storozheva; Andrey T Proshin; Vladimir V Sherstnev; Tatiana P Storozhevykh; Yana E Senilova; Nadezhda A Persiyantseva; Vsevolod G Pinelis; Natalia A Semenova; Elena I Zakharova; Igor A Pomytkin
Journal:  BMC Pharmacol       Date:  2008-01-23

9.  Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis.

Authors:  Xueping Chen; Xiaoyan Guo; Rui Huang; Yongping Chen; Zhenzhen Zheng; Huifang Shang
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

10.  High glucose promotes Aβ production by inhibiting APP degradation.

Authors:  Yi Yang; Yili Wu; Shuting Zhang; Weihong Song
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.